v1
FDA allows controversial bowel drug back on to market.
- NobleID
- NI6P74W50R52S39
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/F074F565
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors